Skip to main content
SpringerLink
Log in

Intravesikale BCG-Therapie des Carcinoma in situ der Harnblase: Vorläufige Ergebnisse

  • Conference paper
BCG-Therapie des oberflächlichen Harnblasenkarzinoms

  • 17 Accesses

Zusammenfassung

Die initiale Behandlung der Wahl bei den meisten Patienten mit Carcinoma in situ ist die intravesikale Instillation von Chemotherapeutika oder Immunstimulantien (Herr et al. 1986a; Jakse 1984; Soloway 1984). In den letzten Jahren weckte Bacillus Calmette-Guérin (BCG) höchstes Interesse auf diesem Gebiet (Herr et al. 1986a; Jakse 1984; Brosman 1985; Herr et al. 1986b; Kavoussi et al. 1988; Pagano et al. 1989; Studer et al. 1987). Erste Ergebnisse des EORTC-Protokolls 30861 werden in diesem Beitrag dargestellt.

Übersetzung aus dem Engl. von Judith Carlen-Stief.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Akaza H, Kameyama S, Koiso K, AsoY und Tokyo BCG Study Group (1991) Ablative and prophylactic effects of BCG Tokyo 172 strain for intravesical treatment in patients with superficial bladder cancer. J Urol 145: 427a (857)

    Google Scholar 

  • Brosman SA (1985) The use of bacillus Calmette-Guerin in the therapy of bladder carcinoma in situ. J Urol 134: 39

    Google Scholar 

  • Brosman S (1989) The influence of Tice strain BCG treatment in patients with transitional cell carcinoma in situ. EORTC GU Group Monograph 6: BCG in superficial bladder cancer, pp 193–205

    Google Scholar 

  • Herr HW, Pinsky CM, Whitmore WF, Sogani PC, Oettgen HF, Melamed MR (1986a) Long term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder. J Urol 135: 265

    PubMed  CAS  Google Scholar 

  • Herr HW et al. (1988) Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer. J. Clin. Oncol 6: 1450–1455

    PubMed  CAS  Google Scholar 

  • Herr HW, Klein EA, Rogatko A (1991) Local BCG failures in superficial bladder cancer. A multivariate analysis of risk factors influencing survival. Eur Urol 19: 97–100

    PubMed  CAS  Google Scholar 

  • Jakse G (1984) Intravesical chemotherapy for carcinoma in situ of the urinary bladder: 5 years later. Eur Urol 10: 289–293

    PubMed  CAS  Google Scholar 

  • Kavoussi LR, Torrence RJ, Gillen DP, et al. (1988) Results of 6 weekly intravesical bacillus Calmette-Guérin instillation on the treatment of superficial bladder tumors. J Urol 139: 935

    PubMed  CAS  Google Scholar 

  • Lamm DL, Crissmann J, Blumenstein B et al. (1989a) Adriamycin versus BCG in superficial bladder cancer: Southwest Oncology Group Study. EORTC Genitourinary Group Monograph 6: BCG in superficial bladder cancer, pp 263–2

    Google Scholar 

  • Lamm DL, Steg A, Boccon-Gibod L et al. (1989b) Complications of bacillus Calmette-Guérin immunotherapy: Review of 2602 patients and comparison of chemotherapy complications. EORTC GU Group Monograph 6: BCG in superficial bladder cancer, pp 335–355

    Google Scholar 

  • Morales A, Eidinger D, Bruce AW (1976) Intracavitary Bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 116: 180

    PubMed  CAS  Google Scholar 

  • Morales A, Nickel C, Wilson JWL (1992) Dose-response of bacillus Calmette- Guérin in the treatment of superficial bladder cancer. J Urol 147:1256–1258

    PubMed  CAS  Google Scholar 

  • Pagano F, Bassi P, Milani C, Meulghini A, Tuccitto G, Garbeglio A, Guazzieri S (1989) Low-dose BCG-Pasteur strain in the treatment of superficial bladder cancer: preliminary results. EORTC GU Group Monograph 6: 253–261

    Google Scholar 

  • Soloway MS (1984) Intravesical and systemic chemotherapy in the management of superficial bladder cancer. Urol Clin North Am 11: 623–635

    PubMed  CAS  Google Scholar 

  • Steg A, Belas M, Lenen CH, Boccon-Gibod L (1989) Intravesical BCG therapy in patients with superficial bladder tumors. EORTC GU Group Monograph 6: 153–160

    Google Scholar 

  • Steg A, Leleu CH, Debré B, Boccon-Gibod L, Sicard D (1989) Systemic bacillus Calmette-Guérin infection in patients treated by intravesical BCG therapy for superficial bladder cancer. EORTC GU Group Monograph 6: BCG in superficial bladder cancer, pp 325–334

    Google Scholar 

  • Studer UE, Ackermann D, Schnyder V, Wartensee M (1987) Immunotherapie bei oberflächlichen Harnblasentumoren. In: Sommerkamp H, Altwein JE, Klippel KF (Hrsg.) Urologischer Workshop Freiburg 1986. Zuckschwert, München, S 129–135

    Google Scholar 

Download references

Author information

Authors and Affiliations

    Authors
    1. G. Jakse
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. R. Hall
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. A. Bono
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. W. Höltl
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. P. Carpentier
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. M. De Pauw
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. R. Sylvester
      View author publications

      You can also search for this author in PubMed Google Scholar

    Consortia

    Mitarbeiter der EORTC-Gruppe

    Editor information

    Editors and Affiliations

    1. Klinik für Urologie, Medizinische Universität zu Lübeck, Ratzeburger Allee 160, D-23538, Lübeck, Deutschland

      Andreas Böhle  & Dieter Jocham  & 

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 1994 Springer-Verlag Berlin Heidelberg

    About this paper

    Cite this paper

    Jakse, G. et al. (1994). Intravesikale BCG-Therapie des Carcinoma in situ der Harnblase: Vorläufige Ergebnisse. In: Böhle, A., Jocham, D. (eds) BCG-Therapie des oberflächlichen Harnblasenkarzinoms. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78843-7_3

    Download citation

    • DOI: https://doi.org/10.1007/978-3-642-78843-7_3

    • Publisher Name: Springer, Berlin, Heidelberg

    • Print ISBN: 978-3-642-78844-4

    • Online ISBN: 978-3-642-78843-7

    • eBook Packages: Springer Book Archive

    Publish with us

    Policies and ethics

    Search

    Navigation